Postoperative brachytherapy and electron beam irradiation for keloids: A single institution retrospective analysis
- Authors:
- Qiwen Duan
- Junhua Liu
- Zhiguo Luo
- Chenhao Hu
View Affiliations
Affiliations: Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Paediatrics and Epidemiology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China
- Published online on: January 27, 2015 https://doi.org/10.3892/mco.2015.498
-
Pages:
550-554
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The aim of the present study was to perform a retrospective analysis of the control rate and toxicity of postoperative brachytherapy and electron beam irradiation for keloids. A retrospective review was performed of 116 keloid patients who underwent postoperative brachytherapy and electron beam irradiation between January 1, 2002 and June 30, 2012. Several different radiotherapy techniques and fractionation schedules were performed in the analysis, including high‑dose rate (HDR) irradiation with 192Ir at 8 Gy/1 fraction (F)+9 Gy/3F or 20 Gy/4F; HDR brachytherapy with 60Co at 20 Gy/4F or 18 Gy/6F; or external beam electron therapy at 26 Gy/13F or 30 Gy/15F. The endpoints of the study were analysis of the control rate and toxicity. The median observation period was 46.5 months (range, 10.0‑120.0 months) for all patients. In total, 18 of the 116 patients relapsed, and 16.7 months (range, 10.0‑30.0 months) was the median time to recurrence for these patients. The control rates for the patients who received hypofractionation (>2 Gy per fraction) and conventional fraction (2 Gy per fraction) were 88.5 and 76.3%, respectively (P=0.043). The control rates for the patients whose calculated biological effective doses (BED) were >30 Gy and <30 Gy were 89.7 and 79.3%, respectively (P=0.104). There were no grade 2 or higher adverse effects based on the Common Terminology Criteria for Adverse Events v3.0 in the late phase. No evidence was identified for a link between radiotherapy and the subsequent occurrence of cancer. The results of the present study indicate that hypofractionated radiotherapy played an important role as an adjuvant therapy following surgical excision of keloids. A BED of >30 Gy appears to be sufficient. No definitive evidence was found for an association between radiotherapy and the occurrence of cancer during the follow‑up, however, more cases and longer follow‑up periods are required.
View Figures |
Figure 1
|
 |
Figure 2
|
 |
Figure 3
|
 |
Figure 4
|
 |
Figure 5
|
 |
Figure 6
|
View References
|
1
|
Rubin P, Soni A and Williams JP: The
molecular and cellular biologic basis for the radiation treatment
of benign proliferative diseases. Semin Radiat Oncol. 9:203–214.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramakrishnan KM, Thomas KP and
Sundararajan CR: Study of 1,000 patients with keloids in South
India. Plast Reconstr Surg. 53:276–280. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakamoto T, Oya N, Nagata Y and Hiraoka M:
The outcome and the adverse effect of postoperative radiotherapy
for keloids: A prospective study with a total dose of 20 GY. Int J
Radiat Oncol Biol Phys 60 Suppl. (1): 549–550. 2004. View Article : Google Scholar
|
|
4
|
Leventhal D, Furr M and Reiter D:
Treatment of keloids and hypertrophic scars: a meta-analysis and
review of the literature. Arch Facial Plast Surg. 8:362–368. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barendsen GW: Dose fractionation, dose
rate and iso-effect relationships for normal tissue responses. Int
J Radiat Oncol Biol Phys. 8:1081–1997. 1982. View Article : Google Scholar
|
|
6
|
Kal HB and Veen RE: Biologically effective
doses of postoperative radiotherapy in the prevention of keloids.
Dose-effect relationship. Strahlenther Onkol. 181:717–723. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ragoowansi R, Cornes PG, Glees JP, Powell
BW and Moss AL: Ear-lobe keloids: treatment by a protocol of
surgical excision and immediate postoperative adjuvant
radiotherapy. Br J Plast Surg. 54:504–508. 2011. View Article : Google Scholar
|
|
8
|
Flickinger JC: A radiobiological analysis
of multicenter data for postoperative keloid radiotherapy. Int J
Radiat Oncol Biol Phys. 79:1164–1170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baltas D, Fehrentz D and Turesson I:
Analysis of late effects data using dose-response models:
application to human skin telangiectasia data. Radiother Oncol.
16:41–53. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chevray PM and Manson PN: Keloid scars are
formed by polyclonal fibroblasts. Ann Plast Surg. 52:605–608. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
ICRP, . International commission on
radiological protection. 1990 recommendations of the international
commission on radiological protection. ICRP Publication 60. Ann
ICRP. 21:1–3. 1991.
|
|
12
|
Ogawa R, Yoshitatsu S, Yoshida K and
Miyashita T: Is radiation therapy for keloids acceptable? The risk
of radiation-induced carcinogenesis. Plast Reconstr Surg.
124:1196–1201. 2009. View Article : Google Scholar : PubMed/NCBI
|
